World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 October 2016
Main ID:  NCT02676011
Date of registration: 03/02/2016
Prospective Registration: No
Primary sponsor: Assiut University
Public title: Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery
Scientific title: Prevention of Brad Arrhythmia Induced by Repeated Succinylcholine by Atropine Sulfate During Gynecological Laparoscopic Surgery: a Randomized Controlled Trial
Date of first enrolment: February 2016
Target sample size: 120
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02676011
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention  
Phase:  Phase 2
Countries of recruitment
Egypt
Contacts
Name:     sayed abd elshafy, M
Address: 
Telephone:
Email:
Affiliation:  associate professor
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female patients 18-50 years scheduled for elective diagnostic gynecological
laparoscopic surgery

Exclusion Criteria:

- Cardiac

- Diabetes Mellitus

- Thyroid disease

- Any endocrine disease



Age minimum: 18 Years
Age maximum: 50 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Bradycardia
Intervention(s)
Drug: IV normal saline
Drug: Atropine mixed with second dose succinylcholine
Drug: IM normal saline
Drug: IV atropine
Drug: IM atropine
Drug: Normal saline mixed with second dose succinylcholine
Primary Outcome(s)
Occurrence of bradycardia [Time Frame: within the first 2 hours during surgery]
Secondary Outcome(s)
Nasopharyngeal secretion [Time Frame: within the first 4 hours during surgery]
Secondary ID(s)
IRB000087133
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history